Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when HQY files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsHealthEquity boosts executive severance packages, adding bonus payouts and equity acceleration
Filed May 8, 2026 · Period ending May 5, 2026 · ~1 min read
Key Changes
-
high
CEO Scott Cutler's severance enhanced to include target annual bonus plus 12 months base salary (or 150% bonus plus 18 months salary if terminated within 18 months of a change in control), significantly increasing cost of CEO turnover.
Item 5.02 verify on EDGAR → -
high
Five senior executives (CFO, Founder, heads of Commercial, Product, and Legal) receive target bonus on top of 12 months base salary, but only if terminated within 18 months of a change in control, creating M&A retention incentives.
Item 5.02 verify on EDGAR → -
medium
New time-based equity grants will accelerate 12 months of vesting upon involuntary termination, reducing the financial penalty for executive departures and increasing severance costs.
Item 5.02 verify on EDGAR → -
medium
Performance-based equity granted after March 25, 2026 remains eligible for prorated vesting based on actual results even after executive leaves, allowing departing leaders to earn performance compensation.
Item 5.02 verify on EDGAR →
Summary
HealthEquity amended employment agreements for six top executives on May 5, 2026, substantially enhancing severance benefits. The changes add target bonus payments to existing base salary severance, with CEO Scott Cutler receiving the most generous package: 12 months salary plus target bonus for standard terminations, or 18 months salary plus 150% of target bonus if terminated around a change in control.
Five other executives receive bonus enhancements only in change-in-control scenarios. Retail investors should note this increases the company's potential severance obligations and signals possible M&A preparation, as the change-in-control provisions create strong retention incentives for the leadership team.
The equity acceleration provisions for grants made after March 25, 2026 further increase costs if executives depart. These changes make executive turnover more expensive but may help retain talent during strategic transitions. Watch for any M&A announcements or strategic reviews in coming quarters, as the timing and structure of these enhanced change-in-control provisions suggest the board may be positioning for potential transaction activity.
Section-by-Section Diff
Event · Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation
HealthEquity enhanced severance packages for six executives, adding target bonus payments and accelerated equity vesting upon termination.
Added in current filing · verify on EDGAR →
the Amendment to Mr. Cutler’s employment agreement provides that his severance payment will include, in addition to 12 months of base salary, an amount equal to his target cash bonus for the year of termination (or 150% of his target cash bonus, in addition to 18 months of base salary, if his termination occurs on or within 18 months following the consummation of a change in control)
CEO Scott Cutler's severance was enhanced to include his target annual bonus on top of 12 months base salary for involuntary termination without cause or resignation for good reason. If termination occurs within 18 months of a change in control, he receives 18 months base salary plus 150% of target bonus. This significantly increases the cost of CEO turnover and provides stronger retention incentives during potential M&A activity.
Added in current filing · verify on EDGAR →
the Amendment to the employment agreements with the Executives other than Mr. Cutler provides that their severance payment will include, in addition to 12 months of base salary, an amount equal to their target cash bonus for the year of termination if their termination occurs on or within 18 months following the consummation of a change in control
Five executives (CFO James Lucania, Founder Stephen Neeleman, Chief Commercial Officer Michael Fiore, Chief Product Officer Sunil Rajasekar, and General Counsel Delano Ladd) received enhanced severance that adds target bonus to 12 months base salary, but only if termination occurs within 18 months of a change in control. This creates change-in-control retention incentives for the senior leadership team.
Added in current filing · verify on EDGAR →
For any time-based restricted stock units granted to the Executives following March 25, 2026 (the “RSUs”), upon a termination by the Company without cause or a resignation by the Executive for good reason prior to a change in control, any RSUs scheduled to vest during the 12-month period following such termination will vest and be settled as of such termination.
Time-based restricted stock units granted after March 25, 2026 will accelerate vesting for the next 12 months' worth of shares upon involuntary termination or resignation for good reason before a change in control. This provides additional severance value beyond cash payments and reduces the penalty for executive departures.
Added in current filing · verify on EDGAR →
For any performance-based restricted stock units granted to the Executive following March 25, 2026 (the “PSUs”), upon a termination by the Company without cause or a resignation by the Executive for good reason prior to a change in control, a prorated number of the PSUs (based on the number of days employed during the performance period) will remain outstanding and eligible to vest based on actual performance of the Company following the completion of the applicable performance period.
Performance-based restricted stock units granted after March 25, 2026 will remain eligible for prorated vesting based on actual company performance even after executive termination. The proration is based on days employed during the performance period. This ensures departing executives can still earn performance compensation for their tenure.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 1, 2026 · How we verify